Landscape of SARS-CoV-2 spike protein-interacting cells in human tissues

Int Immunopharmacol. 2021 Jun:95:107567. doi: 10.1016/j.intimp.2021.107567. Epub 2021 Mar 10.

Abstract

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. However, the mechanism of tissue tropism of SARS-CoV-2 remains unclear. Here, recombinant receptor-binding subdomain 1 of spike protein of SARS-CoV-2 (RBD-SD1) was used as a probe to investigate the potential tropism of SARS-CoV-2 in thirty-three types of normal human tissues. RBD-SD1 probe was observed to interact with cells in reported SARS-CoV-2 infected organs. Interestingly, the RBD-SD1 probe strongly interacted with bone marrow cells in an angiotensin-converting enzyme 2 (ACE2)-independent manner. In addition, SARS-CoV-2 induced the ACE2 mRNA expression in human primary bone marrow cells, suggesting human bone marrow cells may be sensitive to SARS-CoV-2 infection. Therefore, human bone marrow cells could be strongly infected by SARS-CoV-2, which may play an important role in the pathogenesis of COVID-19. These findings provide a deeper understanding of SARS-CoV-2 infection routes, thus contributing to the treatment of COVID-19.

Keywords: Bone marrow cells; Landscape; RBD-SD1 protein probe; SARS-CoV-2.

MeSH terms

  • Angiotensin-Converting Enzyme 2 / biosynthesis
  • Angiotensin-Converting Enzyme 2 / genetics
  • Bone Marrow Cells / cytology
  • Bone Marrow Cells / metabolism
  • Humans
  • Lung / cytology
  • Lung / metabolism
  • Primary Cell Culture
  • Protein Binding
  • Protein Domains
  • SARS-CoV-2 / chemistry*
  • SARS-CoV-2 / metabolism*
  • Spike Glycoprotein, Coronavirus / chemistry*
  • Spike Glycoprotein, Coronavirus / metabolism*
  • Up-Regulation

Substances

  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2